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Abstract
Objectives: The objectives were to describe presentation characteristics and health care utilization infor-
mation pertaining to dizziness presentations in U.S. emergency departments (EDs) from 1995 through
2004.
Methods: From the National Hospital Ambulatory Medical Care Survey (NHAMCS), patient visits to
EDs for ‘‘vertigo-dizziness’’ were identified. Sample data were weighted to produce nationally represen-
tative estimates. Patient characteristics, diagnoses, and health care utilization information were obtained.
Trends over time were assessed using weighted least squares regression analysis. Multivariable logistic
regression analysis was used to control for the influence of age on the probability of a vertigo-dizziness
visit during the study time period.
Results: Vertigo-dizziness presentations accounted for 2.5% (95% confidence interval [CI] = 2.4% to
2.6%) of all ED presentations during this 10-year period. From 1995 to 2004, the rate of visits for ver-
tigo-dizziness increased by 37% and demonstrated a significant linear trend (p < 0.001). Even after
adjusting for age (and other covariates), every increase in year was associated with increased odds of a
vertigo-dizziness visit. At each visit, a median of 3.6 diagnostic or screening tests (95% CI = 3.2 to 4.1)
were performed. Utilization of many tests increased over time (p < 0.01). The utilization of computerized
tomography and magnetic resonance imaging (CT ⁄ MRI) increased 169% from 1995 to 2004, which was
more than any other test. The rate of central nervous system diagnoses (e.g., cerebrovascular disease or
brain tumor) did not increase over time.
Conclusions: In terms of number of visits and important utilization measures, the impact of dizziness
presentations on EDs is substantial and increasing. CT ⁄ MRI utilization rates have increased more than
any other test.
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D izziness is one of the most common reasons thatpatients present to physician’s offices, hospitaloutpatient departments, and emergency depart-
ments (EDs) in the United States.1 Previous studies
report important information about dizziness presenta-
tions to EDs,2,3 but the findings from these studies are
limited because of single-center designs or brief data
collection periods or a focus on only a specific cause of
dizziness. To our knowledge, no study to date has used a
population-based sampling design and data collected
over many years to determine details about dizziness in
its broadest sense. Studying dizziness is important
because medical decision-making begins with the symp-
tom presentation. This type of study is necessary to
determine basic ‘‘real-world’’ epidemiologic and health
care utilization information that can bring new knowl-
edge about the impact of dizziness and identify steps to
optimizing patient care and health care utilization.
Our study sought to determine important information
on the presentation of dizziness in the ED by analyzing
10 years of data collected annually as a part of the
National Hospital Ambulatory Medical Care Survey
(NHAMCS). Specifically, the study planned to describe
presentation characteristics and health care utilization
information about dizziness presentations, assess trends
over time, and use this information to inform future
research directions.
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This study presents a secondary analysis of data
collected for the NHAMCS for the 10-year period of
1995 to 2004.4 All information contained in this data-
base has been completely deidentified in accordance
with the Health Insurance Portability and Accountabil-
ity Act (HIPAA) and the data are publicly available. This
study was determined to be exempt from review by the
University of Michigan Institutional Review Board.
Study Setting and Population
Details of the procedures involved in NHAMCS data
collection have been published elsewhere.5 In brief, the
NHAMCS is a cross-sectional, annual, four-stage prob-
ability sample of visits to randomly selected, noninstitu-
tional, general, and short-stay hospitals in the United
States with EDs or outpatient departments. The sample
excludes federal, military, and Veterans’ Affairs hospi-
tals. Geographical primary sampling units are identified
first, and then hospitals are selected within those pri-
mary sampling units. EDs are selected from those hos-
pitals, and individual patient-visits from those EDs are
systematically selected. Trained staff from the National
Center for Health Care Statistics (NCHS) collect data
from patient medical records using standardized collec-
tion forms during a randomly assigned 4-week data
period for each of the sampled hospitals. Completed
forms are reviewed at NCHS, where data abstraction
and medical coding are performed.
Study Protocol
ED visits for ‘‘dizziness’’ were identified by using the
variable ‘‘patient’s reason for visiting’’ (RFV) the ED.
The RFV variable was developed by the NCHS to code
patients’ main complaints or reasons for seeking care.6
Each visit is allowed up to three RFVs. We selected
patients with the RFV of ‘‘vertigo-dizziness’’ in any of
the three RFV fields. The symptoms ‘‘vertigo’’ and
‘‘dizziness’’ are combined into the variable ‘‘vertigo-
dizziness’’ in NHAMCS, so ‘‘vertigo’’ presentations can-
not be separated from ‘‘dizziness’’ presentations. The
10-year period was chosen for this study to maximize
the accuracy of estimates and enable the analysis of
trends over time based on the independent cross-sec-
tional samples in each year. For each vertigo-dizziness
visit, we extracted key patient demographic information
including age, gender, race, and ethnicity. We only
included the variable ‘‘patient’s condition at the time of
triage’’ from 1997 to 2004 because the coding of this
variable changed in 1997. The following codes are used
to describe the patient’s condition at the time of triage:
emergent (need to be seen in less than 15 minutes),
urgent (need to be seen in 15–60 minutes), semiurgent
(need to be seen in 1–2 hours), nonurgent (need to be
seen in 2–24 hours), and unknown ⁄ not recorded. Other
accompanying RFVs were also extracted for analysis
purposes.
Up to three discharge diagnoses were extracted
based on coding using the International Classification
of Diseases, Ninth revision, Clinical Modification
(ICD-9-CM). Screening and diagnostic tests ordered or
performed, length of stay, medications prescribed or
provided (henceforth, medications prescribed), and dis-
position were also extracted for each qualifying ED
visit. Computerized tomography (CT) and magnetic res-
onance imaging (MRI) are combined into a single vari-
able, CT ⁄ MRI, by the NHAMCS.
Data Analysis
According to the complex multistage design of the
annual NHAMCS sample, a sampling weight is com-
puted for each visit by NCHS staff that takes all stages
of sampling into account. Complete details about the
weighting methodology used by NHAMCS can be
found elsewhere.4 This sampling weight is used to cal-
culate unbiased, nationally representative visit-level
estimates in each sample year and includes four basic
components: inflation by reciprocals of selection proba-
bilities, adjustment for nonresponse, population ratio
adjustments, and weight smoothing. In 2004, for the
first time, extra weights for nonresponding hospitals
were shifted to responding hospitals in reporting peri-
ods within the same quarter of the year. The shift in
nonresponse adjustment did not significantly affect any
of the overall annual estimates. Estimated standard
errors reflecting sampling variability in estimates due to
the complex, multistage design of the NHAMCS sample
in each year were computed using approximations
based on Taylor Series Linearization in the SUDAAN
software (Version 9.0, Research Triangle Institute,
Research Triangle Park, NC). Additional data analyses
and management were performed using the SAS soft-
ware (Version 9.1.3, SAS Institute, Cary, NC), and
because all analyses focused on the specific subclass of
ED visits for vertigo-dizziness from the full NHAMCS
sample, methods appropriate for subclass analyses
were utilized in SUDAAN and SAS.7
The data analysis consisted of three parts: a descrip-
tive analysis, a trend analysis, and multivariable logistic
regression modeling. Weighted estimates of descriptive
statistics (including proportions, rates, and medians)
and their standard errors in addition to 95% confidence
intervals for the descriptive parameters were calculated
in SUDAAN, and estimated rates were calculated using
methodology described by NCHS staff.8 Because the
codes for race were last updated in 2000, we only used
data on race from 2000–2004 to summarize the distribu-
tion of race. Because some screening and diagnostic
test categories have been added to the NHAMCS over
the years, only data from years 2003 and 2004 were
used to estimate the median number of tests at each
visit. In addition, the medical screening exam and the
mental status screening test were excluded from the
NHAMCS list of screening and diagnostic tests.
Trends in the estimated rates of presentations to the
ED for vertigo-dizziness per 1,000 ED visits and per
1,000 U.S. population9,10 were analyzed using weighted
least squares regression analyses, where the dependent
variable was the estimated rate, the independent vari-
able was the number of years since 1995, and the
weight was the inverse of the standard error for a
given rate estimate, meaning more precise estimates
with lower standard errors would get more weight.
Trends in recorded diagnoses were also assessed using
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weighted least squares regression. Linear trends with
p < 0.05 were considered as evidence of increasing
rates.
Multivariable logistic regression modeling was used
so that we could adjust for age when assessing the tem-
poral pattern of vertigo-dizziness presentations over
the 10-year period. The dependent variable in the model
was an indicator of whether vertigo-dizziness was listed
as a reason for the visit (1 = yes, 0 = no), and the sub-
population of all ED visits in the NHAMCS data set was
analyzed. Independent variables in the model included
year of the visit, age (modeled continuously), gender,
and race. Race was categorized as white, African
American, or other, so that information from all
10 years could be included. A separate multivariable
logistic regression model was also used to adjust for
age when assessing the temporal pattern of CT ⁄ MRI
utilization for visits with vertigo-dizziness as a reason
for visit. In this model, the dependent variable was an
indicator of receiving CT ⁄ MRI (1 = yes, 0 = no), and the
subpopulation of visits with vertigo-dizziness as a
reason for the visit was analyzed. The independent
variables included in this model were year of the visit,
age, gender, and race.
RESULTS
Presentation information
Over the 10-year period included in this study, a total
of 7,160 sampled visits for vertigo-dizziness were identi-
fied out of a total of 285,622 total sampled ED visits.
This number represents an estimate of nearly 26 million
ED visits for vertigo-dizziness in the United States.
These numbers translate to a rate of 25.0 ED visits for
vertigo-dizziness per 1,000 ED visits (95% confidence
interval [CI] = 22.9 to 27.1). Equivalently, vertigo-dizzi-
ness visits account for about 2.5% (95% CI = 2.4% to
2.6%) of all ED visits. Table 1 presents additional esti-
mated rates per 1,000 ED visits for various population
subgroups. From 1995 to 2004, the rate of vertigo-dizzi-
ness visits increased by 37% (Figure 1). The weighted
least squares regression analysis showed that the rate
of increase over the study period was significant
(p < 0.001). After stratifying by age group, increases in
visits from 1995 to 2004 ranged from a 15% increase in
those age 45–64 years to a 67% increase in those age
‡65 years. When trends were analyzed as rate of ver-
tigo-dizziness presentation per 1,000 U.S. population,
evidence of a similar significant linear trend (p < 0.001)
was also demonstrated (Figure 2). The temporal
increase in the prevalence of vertigo-dizziness presenta-
tions remained significant in the visit-level multivariable
logistic regression model controlling for age and the
other covariates. In this model, every 1-year increase
was associated with a 2.0% increase in the odds of a
vertigo-dizziness presentation (odds ratio [OR] = 1.02,
95% CI = 1.01 to 1.03).
The most common accompanying RFVs for the
sampled vertigo-dizziness visits were nausea (12.9% of
visits; 95% CI = 11.9% to 13.9%), headache (11.7% of
visits; 95% CI = 10.7% to 12.6%), generalized weakness
(10.7% of visits; 95% CI = 9.8% to 11.6%), vomiting
(8.0% of visits; 95% CI = 7.1% to 8.9%), and shortness
of breath (4.1% of visits, 95% CI = 3.5% to 4.6%). When
vertigo-dizziness was the principal reason for the visit
(i.e., RFV1), more than one-third (36.4%) of visits did
not have any other RFV recorded.
The most common diagnoses recorded for the sam-
pled vertigo-dizziness visits are shown in Figure 3. The
nonspecific diagnosis of ‘‘dizziness and giddiness’’
(ICD-9-CM code 780.4) was recorded in more than one-
fifth of all visits, making it by far the most common
diagnosis. Cerebrovascular diagnoses were rarely
recorded (3.9% of visits). No brain tumor (ICD-9-CM
191 or 192) or vertigo of central origin diagnosis (ICD-
9-CM 386.2) was recorded at any sample visit over this
10-year period. The rate of cerebrovascular diagnoses
(ICD-9-CM codes 430–437) did not demonstrate evi-
dence of a significant linear increase. Likewise, rates of
injury diagnoses (ICD-9-CM 800–959) did not demon-
strate a significant linear increase. Trends in brain
tumor diagnoses could not be analyzed because no
sample visits for vertigo-dizziness over this 10-year per-
iod had a brain tumor diagnosis recorded.
Health Care Utilization
An estimated median 3.6 screening or diagnostic tests
(95% CI = 3.2 to 4.1, years 2003 and 2004) were ordered
or provided at each visit. An estimated 13.1% (95%
CI = 11.0% to 15.3%) of visits for vertigo-dizziness had
no tests ordered or provided. On the other hand, 10 or
more tests were ordered or provided in approximately
14% (95% CI = 11% to 16%) of all visits. The most com-
monly ordered tests are listed in Table 2. Many tests
(i.e., complete blood count [CBC], electrocardiogram
[ECG], glucose, blood urea nitrogen, creatinine, chest
x-ray, urinalysis, and CT ⁄ MRI) demonstrated a statisti-
cally significant (p < 0.01) increase in utilization over
time. CT ⁄ MRI utilization increased 169% from 1995 to
2004, an increase greater than any other test. Although
the rates of CT ⁄ MRI use were highest in those
‡65 years of age (38% of visits by 2004), those aged 20–
44 years had the largest increase (281%) from 1995 to
2004 (Figure 4). After adjusting for age and the other
covariates in the visit-level multivariable logistic regres-
sion model, every 1-year increase was associated a 14%
increase in the odds of having a CT ⁄ MRI (OR = 1.14,
95% CI = 1.11 to 1.18) among those visiting EDs with
vertigo-dizziness as a reason for the visit.
The estimated median length of stay in the ED for
vertigo-dizziness visits was 3.0 hours (95% CI = 2.9 to
3.1, years 2001–2004). Median length of stay increased
from 2.8 hours (95% CI = 2.7 to 3.2) in 2001 to 3.3 hours
(95% CI = 3.1 to 3.4) in 2004. More than 20% (20.2%;
95% CI = 18.3% to 22.1%) of all visits for vertigo-dizzi-
ness resulted in a hospital admission. An estimated
median of 0.8 medications (95% CI = 0.7 to 0.9, years
2001–2004) were prescribed at each visit. An estimated
27.6% of visits (95% CI = 25.4% to 29.9%) had no medi-
cations recorded. The most common medications pre-
scribed were meclizine (15.2% of visits; 95% CI = 13.8%
to 16.7%), promethazine (8.4% of visits, 95% CI = 7.1%
to 9.7%), acetaminophen (6.5% of visits; 95% CI =
5.5% to 7.4%), normal saline (5.5% of visits; 95%
CI = 4.3% to 6.6%), and aspirin (4.4% of visits; 95%
CI = 3.4% to 5.5%).
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DISCUSSION
The most important findings of this descriptive study
are that 1) vertigo-dizziness presentations are increas-
ing as a percent of all visits to U.S. EDs and 2) the use
of CT ⁄ MRI in vertigo-dizziness presentations has dra-
matically increased over time. Previous analyses of
NHAMCS data reveal that vertigo-dizziness is among
the most common reasons that a patient presents to the
ED.1 The current study supplements that finding by
showing that vertigo-dizziness presentations are also
increasing as a rate per 1,000 ED visits per year. Simply
based on this information alone, it can be concluded
that vertigo-dizziness presentations have a substantial
and growing impact on EDs. The reason for the
increase—relative to all ED presentations—is not clear.
Patients with dizziness may increasingly perceive the
need for an ED evaluation. Indeed, individuals with
acute-onset dizziness are now instructed by the Ameri-
can Stroke Association public education message to call
9-1-1 immediately.11 Access to EDs has probably not
improved over this time, but it is possible that outpa-
tient physicians are increasingly instructing patients
who call reporting dizziness to go to the ED. The aging
of the population seems to be an important factor
because the largest increase in rate of presentation was
Table 1
Demographic and Clinical Information for Vertigo-Dizziness Visits to the ED
Variable n
Estimated
















Overall 7,160 25,867 1,034,758 25.0 (22.9, 27.1) — 1995–2004
Age groups (years)*
£19 628 2,380 300,530 7.9 (6.8, 9.0) 9.2 (8.3, 10.1) 1995–2004
20–44 2,570 9,469 401,286 23.6 (21.3, 25.9) 36.6 (35.1, 38.1)
45–64 1,823 6,323 177,701 35.6 (32.2, 39.0) 24.4 (23.1, 25.7)
65+ 2,139 7,695 155,241 49.6 (44.7, 54.4) 29.7 (28.2, 31.3)
Male 2,822 10,223 484,752 21.1 (19.2, 23.0) 39.5 (38.1, 41.0) 1995–2004
Race
White 3,360 10,997 414,457 26.5 (24.3, 28.8) 76.3 (73.6, 79.0) 2000–2004
African American 986 2,922 118,683 24.6 (20.8, 28.4) 20.3 (17.7, 22.9)
Asian 182 337 10,670 31.6 (22.2, 41.0) 2.3 (1.7, 3.0)
Other 54 157 5,972 26.4 (13.0, 39.7) 1.1 (0.5, 1.6)
Ethnicity
Non-Hispanic 5,607 20,329 799,175 25.4 (23.2, 27.7) 78.6 (76.5, 80.6) 1995–2004
Hispanic 801 2,462 110,544 22.3 (19.1, 25.4) 9.5 (8.1, 10.9)
Unknown 752 3,076 125,039 24.6 (19.7, 29.5) 11.9 (10.0, 13.8)
Immediacy
<15 minutes 1,266 4,551 150,484 30.2 (26.6, 33.9) 20.9 (18.9, 22.9) 1997–2004
15–60 minutes 2,357 8,080 279,363 28.9 (26.0, 31.8) 37.1 (35.0, 39.3)
>1–2 hours 1,006 3,281 148,657 22.1 (19.0, 25.2) 15.1 (13.5, 16.6)
>2–24 hours 346 1,296 88,333 14.7 (11.8, 17.6) 6.0 (4.9, 7.0)
Unknown ⁄ no triage 1,219 4,559 181,029 25.2 (21.4, 29.0) 21.0 (18.4, 23.5)
CI = confidence interval; ED = emergency department.
*Median age all visits, 47.4 years (95% CI = 46.2 to 48.6 years).
Figure 1. Rates of visits per 1,000 ED visits for vertigo-dizzi-
ness presentations to United States emergency departments
(EDs), all ages and stratified by age group. A weighted least
squares regression analysis showed a significant linear trend
(p < 0.001).
Figure 2. Rates of visits per 1,000 U.S. population for vertigo-
dizziness presentations to U.S. emergency departments (EDs). A
weighted least squares regression analysis showed a significant
linear trend (p < 0.001).
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seen in the age group ‡65 years and because dizziness
symptoms are strongly linked to increasing age.12 How-
ever, vertigo-dizziness presentations have increased per
1,000 U.S. population. In addition, age did not explain
the increase in the prevalence of dizziness presentations
when its influence was assessed using the visit-level
multivariable logistic regression model.
Screening and diagnostic tests are frequently ordered
in patients who present to the ED for dizziness, but the
contribution these tests make to patient care is not
clear. This study shows that CT ⁄ MRI utilization has
grown more rapidly than any other test in dizziness
evaluations. Despite this finding, central nervous system
diagnoses did not increase. These findings may stem
from uncertainty in the clinical evaluation of dizziness
presentations in general13,14 and specifically from a
widespread emphasis of dizziness as a stroke symptom.
In addition to the public messages warning of stroke in
acute dizziness,11 the medical literature emphasizes
dizziness as a stroke symptom as well.15–18 One study
suggests that stroke could even be the cause in 25%
of acute ‘‘isolated dizziness’’ (i.e., dizziness without
other central nervous system signs or symptom) pre-
sentations.19 However, stroke was found to be a very
rare cause of dizziness presentations to the ED in a
population-based stroke surveillance study that used a
method for validating stroke.3 In that study, acute
cerebrovascular causes were diagnosed in only 3.2%
(53 of 1,666) of all dizziness presentations and in only
0.7% (9 of 1297) of those presenting with ‘‘isolated
dizziness.’’ In the current analysis of NHAMCS data,
we found that only 3.9% of patients presenting for
vertigo-dizziness received a cerebrovascular diagnosis,
with most of these diagnoses coded as the more vague
categories of ‘‘transient cerebral ischemia’’ (ICD-9-CM
code 435) or ‘‘acute or ill-defined, cerebrovascular
disease’’ (ICD-9-CM codes 436, 437).
To the best of our knowledge, no study presents a
validated method for discriminating dizziness caused by
stroke from nonstroke causes at the bedside. As a
result, frontline physicians may be increasingly using
Figure 3. Recorded diagnoses for vertigo-dizziness presenta-
tions, 1995–2004.
Table 2
Screening or Diagnostic Test Utilization for Vertigo-Dizziness





Test (95% CI) Year Included
CBC 55.8 (53.8, 57.8) 1997–2004
ECG 43.3 (41.6, 45.0) 1995–2004
Glucose 33.2 (30.3, 36.1) 2001–2004
BUN 32.6 (29.8, 35.5) 2001–2004
Creatinine 31.5 (28.6, 34.5) 2001–2004
Pulse oximetry 29.4 (27.5, 31.4) 1995–2004
Electrolytes 28.9 (25.1, 32.7) 2003–2004
Chest x-ray 24.9 (23.4, 26.4) 1995–2004
Urinalysis 22.0 (20.6, 23.5) 1995–2004
Cardiac monitor 18.0 (16.5, 19.5) 1995–2004
CT ⁄ MRI 16.7 (15.5, 17.9) 1995–2004
BUN = blood urea nitrogen; CBC = complete blood count;
CI = confidence interval; CT ⁄ MRI = computerized tomography
and magnetic resonance imaging; ECG = electrocardiogram.
Figure 4. Percentage of vertigo-dizziness visits to the emer-
gency department (ED) in which computerized tomography or
magnetic resonance imaging (CT ⁄ MRI) was ordered or per-
formed, all ages and stratified by age group. The overall trend
and the trend for each age group, other than age £19 years,
was significant (p < 0.01).
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imaging studies to make this critical distinction. How-
ever, this approach is problematic. Not only is stroke a
rare cause of dizziness in the ED, but the sensitivity of
CT for acute stroke is very low.20–22 MRI—a more sensi-
tive test for stroke—is not readily available or practical
for routine ED use. Since CT ⁄ MRI has been shown to
have a strong association with increased ED length of
stay,23 these tests may be increasing length of stay but
making very little contribution to diagnosis or care.
In the steps to optimizing both patient care and
health care utilization, this study identifies some impor-
tant future research directions. A clinical decision rule
assessing stroke risk could make an important contribu-
tion to optimizing neuroimaging utilization and patient
care. The ideal clinical decision rule would help to
determine which patients with dizziness need a neuroi-
maging study and which patients do not. Similar
research approaches may be important for addressing
utilization of other tests that were not further explored
in this analysis. Perhaps most importantly, future
research should evaluate how processes of care (i.e.,
what is done by physicians at the time of service) are
linked to important outcomes so that emphasis can be
placed on the processes that are proven to make a
positive contribution. The importance of these future
research directions is supported by the finding that diz-
ziness presentations are substantial and increasing.
LIMITATIONS
To our knowledge, this was the largest study conducted
to date of visits for dizziness in EDs and provides sev-
eral important insights. Nonetheless, the study has
some limitations that warrant mention. Medical record
review studies such as NHAMCS are susceptible to cer-
tain types of error.24 The NHAMCS study addresses
these potential sources of error by using explicit proto-
cols for case selection, specially trained abstractors,
well-defined variables, and blinding of chart reviewers
to hypotheses. In addition, quality control procedures
are in place. The keying error rate for nonmedical items
averages less than 1%; for items requiring medical cod-
ing, discrepancy rates average under 2%.4 Health care
providers contributing to the NHAMCS do not follow a
protocol to categorize and record diagnoses, and no
method is used to validate diagnoses that were
recorded. In the NHAMCS data set, the symptom of
‘‘vertigo’’ cannot be analyzed separately from ‘‘dizzi-
ness’’ because these symptoms were classified into the
single RFV code, vertigo-dizziness. It is unlikely that the
use of additional dizziness symptom categories in NHA-
MCS would be more informative because physicians do
not follow a protocol for documenting symptom type
and also because dizziness symptoms are known to be
unclear, inconsistent, and unreliable.25 It is possible that
CT ⁄ MRI utilization is increasing for reasons other than
stroke screening purposes. We also searched for brain
tumor and ‘‘vertigo of central origin’’ diagnoses, but
found none over this study period. Injury may be
another common reason for CT ⁄ MRI use in dizziness
presentation, but the rate of injury diagnoses did not
increase over time. Importantly, the NHAMCS study
does not follow patients or determine outcomes. As a
result, we can only speculate about how current care
contributes to patient outcomes until we have more
detailed research.
CONCLUSIONS
In terms of number of visits and important utilization
measures, the impact of dizziness presentations on EDs
is substantial and increasing. CT ⁄ MRI utilization rates
have increased more than any other test.
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